Browse by Attribute
Browse by Column

China regulator fines two pharma firms 320 million yuan for monopolistic behaviour

2023/05/31

On May 28, China's market regulator said it had fined two pharmaceutical companies 320 million yuan for entering into a monopolistic deal and abusing dominant market position. The State Administration of Market Regulation fined Grand Pharmaceutical 136 million yuan and confiscated 149 million yuan of "illegal revenue" and fined Wuhan Healcare Pharmaceuticals 4.13 million yuan and confiscated slightly over 30 million yuan of its revenue.




Click Ranking

People watch


Chen Jun: Accumulation and Sublimation
It is lucky for Chen Jun to began his career in the IP industry 14 years ago when the first group of IP managers for businesses appeared on the stage in China and he has been in the industry.

Foxconn in Those Years
It was this “Whampoa Military Academy” for IP that educated China’s first batch of corporate IP management personnel. Many of these engineers left Foxconn in the years since.

more
2018 ANNUAL INVENTORY OF THE The Progress and Challenges of Copyright Industry in China Interview with Cheng Lingjun, Intellectual Property Director of Joyoung Co., Ltd. Interview with Chen Lingpei, General Manager of IP Division, Autodesk, Inc. (Greater China) Constant Accumulation Makes theLatecomers Surpass—Interview with Huang Lu, Director of IP Center of Humanwell Healthcare (Gr Between Lawyer and Manager —Interview with Xia Feng, the Chief IP Counsel of Greater China & Asia-Pacific, Honeywell (China) Patent Prosecution Highway and its Application Overview of EU copyright levy system – in the case of mobile phones